Chetan Dhamne
About
Chetan Dhamne is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Chetan Dhamne has authored 47 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Public Health, Environmental and Occupational Health and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Chetan Dhamne's work include Acute Lymphoblastic Leukemia research (14 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Lymphoma Diagnosis and Treatment (8 papers). Chetan Dhamne is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Lymphoma Diagnosis and Treatment (8 papers). Chetan Dhamne collaborates with scholars based in India, Singapore and United States. Chetan Dhamne's co-authors include Yeonseok Chung, Laurence J.N. Cooper, Dat Q. Tran, Amin M. Alousi, Gaurav Narula, Nirmalya Roy Moulik, Shripad Banavali, Cynthia E. Herzog, Maya Prasad and Mary T. Austin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.
In The Last Decade
Chetan Dhamne
39 papers receiving 275 citations
Peers
Chetan Dhamne
Afsaneh Tehranian Iran
C Iavazzo Greece
Rolla Abu‐Arja United States
Nobuyuki Hyakuna Japan
Minako Iida Japan
Suk Bong Koh South Korea
Michihiro Uchiyama Japan
Karen Mandel Canada
Blanca Molina Spain
Kyu-Rae Kim South Korea
Citations per year, relative to Chetan Dhamne Chetan Dhamne (= 1×)
peers
Afsaneh Tehranian
Countries citing papers authored by Chetan Dhamne
Since
Specialization
Citations
This map shows the geographic impact of Chetan Dhamne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chetan Dhamne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chetan Dhamne more than expected).
Fields of papers citing papers by Chetan Dhamne
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Chetan Dhamne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chetan Dhamne. The network helps show where Chetan Dhamne may publish in the future.
Co-authorship network of co-authors of Chetan Dhamne
This figure shows the co-authorship network connecting the top 25 collaborators of Chetan Dhamne. A scholar is included among the top collaborators of Chetan Dhamne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chetan Dhamne. Chetan Dhamne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Dhamne, Chetan, et al.. (2024). Combination of low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical hodgkin lymphoma (rrhl), 5-year experience from tata memorial centre. SHILAP Revista de lepidopterología. 9(4). S4–S4.
2.
Dhamne, Chetan, Shilpushp J Bhosale, Jigeeshu V. Divatia, et al.. (2024). Epilepsia Partialis Continua as a Sequelae of Measles Infection in Children With Hematolymphoid Malignancies. JCO Global Oncology. 10(10). e2300399–e2300399.
3.
Moulik, Nirmalya Roy, Gaurav Chatterjee, Chetan Dhamne, et al.. (2024). Treatment‐Free Remissions in Children With Chronic Myeloid Leukemia (CML ): A Prospective Study From the Tata Memorial Hospital (TMH ) Pediatric CML (pCML ) Cohort. American Journal of Hematology. 100(2). 210–217.
4.
Dhamne, Chetan, et al.. (2024). Prevalence and outcome of candidemia among paediatric cancer patients: A single centre experience from India. Journal de Mycologie Médicale. 34(4). 101510–101510.
5.
Kuick, Chik Hong, Shui Yen Soh, M. K. Wong, et al.. (2023). Clinicopathological and treatment response characteristics of updated rhabdomyosarcoma histomolecular subtypes: An Asian population‐based study. Asia-Pacific Journal of Clinical Oncology. 21(1). 65–76.
6.
Desai, P. B., Bhausaheb Bagal, Chetan Dhamne, et al.. (2023). Navigating the neutropenic abyss with granulocyte transfusions: Retrospective single‐center analysis of effectiveness and safety in India. Journal of Clinical Apheresis. 38(6). 703–710.
7.
Dhamne, Chetan, Nikhil Patkar, Gaurav Chatterjee, et al.. (2023). KITexon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia withRUNX1::RUNX1T1. Pediatric Blood & Cancer. 71(2). e30791–e30791.
8.
Moulik, Nirmalya Roy, Chetan Dhamne, Gaurav Narula, et al.. (2023). Does granulocyte transfusion help pediatric cancer patients with sepsis?. Pediatric Blood & Cancer. 70(9). e30547–e30547.
9.
Chatterjee, Gaurav, Sitaram Ghogale, Nilesh Deshpande, et al.. (2023). 15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges. European Journal Of Haematology. 112(1). 122–136.
10.
Dhamne, Chetan, Nirmalya Roy Moulik, Prashant Tembhare, et al.. (2023). Treatment of Pediatric Acute Promyelocytic Leukemia with Retinoic Acid and Arsenic Trioxide along with Chemotherapy. The Indian Journal of Pediatrics. 91(6). 564–570.
11.
Moulik, Nirmalya Roy, Chetan Dhamne, H. K. Jain, et al.. (2023). Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India. Annals of Hematology. 102(10). 2835–2844.
12.
Moulik, Nirmalya Roy, Chetan Dhamne, Maya Prasad, et al.. (2022). Pediatric cancer‐associated thrombosis: Analysis from a tertiary care cancer center in India. Pediatric Blood & Cancer. 70(2). e30096–e30096.
13.
Prasad, Maya, Nirmalya Roy Moulik, Chetan Dhamne, et al.. (2022). Impact of a pediatric oncology nutrition program: Lessons learnt over a decade. Pediatric Blood & Cancer. 69(7). e29728–e29728.
14.
Monsereenusorn, Chalinee, Ana Patricia Alcasabas, Amos Hong Pheng Loh, et al.. (2022). Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study. Pediatric Blood & Cancer. 69(4). e29556–e29556.
15.
Prasad, Maya, Chetan Dhamne, Nirmalya Roy Moulik, et al.. (2022). Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India. Pediatric Hematology and Oncology. 39(5). 427–440.
16.
Moulik, Nirmalya Roy, Gaurav Narula, Maya Prasad, et al.. (2020). Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in India. Pediatric Blood & Cancer. 67(11). e28682–e28682.
17.
Narula, Gaurav, Chetan Dhamne, Nirmalya Roy Moulik, et al.. (2020). Assessment of tumor Epstein-Barr Virus status and its impact on outcomes in intermediate and high-risk childhood classic Hodgkin Lymphoma treated at a tertiary cancer center in India. Leukemia & lymphoma. 61(13). 3217–3225.
18.
Jain, H. K., Prashant Tembhare, Nikhil Patkar, et al.. (2020). Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALL. Blood Cells Molecules and Diseases. 85. 102465–102465.
19.
Salunke, Abhijeet Ashok, et al.. (2014). Valgus deformity caused by dysplasia epiphysealis hemimelica in the knee. Journal of Postgraduate Medicine. 60(3). 351–351.
20.
Dhamne, Chetan, Yeonseok Chung, Amin M. Alousi, Laurence J.N. Cooper, & Dat Q. Tran. (2013). Peripheral and Thymic Foxp3+ Regulatory T Cells in Search of Origin, Distinction, and Function. Frontiers in Immunology. 4. 253–253.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Afsaneh Tehranian Breakdown of academic impact, for papers by C Iavazzo Breakdown of academic impact, for papers by Rolla Abu‐Arja Breakdown of academic impact, for papers by Nobuyuki Hyakuna Breakdown of academic impact, for papers by Minako Iida Breakdown of academic impact, for papers by Suk Bong Koh Breakdown of academic impact, for papers by Michihiro Uchiyama Breakdown of academic impact, for papers by Karen Mandel Breakdown of academic impact, for papers by Blanca Molina Breakdown of academic impact, for papers by Kyu-Rae Kim